Article Information
History
- March 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joanna Luczkowiak1,
- Gonzalo Rivas2,
- Nuria Labiod1,
- Fátima Lasala1,
- Marta Rolo2,
- Jaime Lora-Tamayo3,4,
- Mikel Mancheno-Losa3,
- David Rial-Crestelo3,
- Alfredo Pérez-Rivilla2,5,
- María D. Folgueira1,2,5 and
- Rafael Delgado1,2,4,5,*
- 1Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
- 2Department of Microbiology. Hospital Universitario 12 de Octubre, Madrid, Spain
- 3Department of Internal Medicine. Hospital Universitario 12 de Octubre, Madrid, Spain
- 4CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III)
- 5School of Medicine. Universidad Complutense. Madrid, Spain
- ↵*Corresponding author: Dr. Rafael Delgado, Servicio de Microbiología, Hospital Universitario 12 de Octubre, Avenida de Córdoba sn, Madrid 28041 Spain, Phone +34 669580985, e-mail: rafael.delgado{at}salud.madrid.org
Posted March 20, 2022.
Potency and Breadth of Neutralization after 3 doses of mRNA vaccines in COVID-19 Convalescent and Naïve individuals
